Kappa-opioid receptor antagonism: a mechanism for treatment of relief drinking?
Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. Electronic address: markus.heilig@mail.nih.gov.
Markus
M
Heilig
Department of Physiology and Pharmacology, College of Veterinary Medicine, The University of Georgia, Athens, Georgia.
Jesse R
JR
Schank
D000437:Alcoholism / Q000378:metabolism*; D000818:Animals; D066274:Central Amygdaloid Nucleus / Q000378:metabolism*; D002492:Central Nervous System Depressants / Q000008:administration & dosage*; D000431:Ethanol / Q000008:administration & dosage*; D008297:Male; D011957:Receptors, Opioid / Q000378:metabolism*; D017473:Receptors, Opioid, kappa / Q000378:metabolism*
D002492:Central Nervous System Depressants; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; C030738:dynorphin receptor; D000431:Ethanol